Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gary Harton; Solange Glaize

Premium

BlueGnome has appointed Gary Harton to be its IVF business development manager for the Americas. Harton will be responsible for BlueGnome's 24sure product line, an array-based aneuploidy screening technology that is being used in a number of studies to improve in vitro fertilization success rates.

Harton joined BlueGnome from Reprogenetics, where he was the head of molecular genetics R&D. Prior to Reprogenetics, Harton held various roles at the Genetics & IVF Institute. He is currently the chair of the European Society of Human Reproduction & Embryology's Preimplantation Genetic Diagnosis Consortium's steering committee.


Agilent Technologies has appointed Solange Glaize to serve as vice president and chief accounting officer, effective immediately. Glaize has already held various posts at Agilent, including senior director of finance for the life sciences solutions unit, and VP of finance and group CFO of the Life Sciences Group. Glaize will receive an increase in her base salary to $285,000.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.